Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Acura Pharmaceuticals and King Pharmaceuticals have announced that Acura's new drug application for Acurox tablets has been accepted for filing by the FDA with a priority review classification.
Subscribe to our email newsletter
The user fee goal date under the Prescription Drug User Fee Act is June 30, 2009. The FDA may grant a new drug application a priority review classification if its assessment of conditions and information available at the time the application is filed indicates the drug product has the potential to provide, among other things, significant improvements compared to marketed products.
Acurox is an immediate release opioid analgesic, has a proposed indication for relief of moderate-to-severe pain and is designed to deter common methods of misuse and abuse.